Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms
Biosensors and Bioelectronics · 2023-06 · 229 · 115221
DOI: 10.1016/j.bios.2023.115221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-06. Verfasst von Yan Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, 85721, United States. Hauptthemen laut MEDLINE: COVID-19, Biosensing Techniques. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Antibody assay for SARS-CoV-2 has become increasingly important to track latent and asymptomatic infections, check the individual's immune status, and confirm vaccine efficacy and durability. However, current SARS-CoV-2 antibody assays require invasive blood collection, requiring a remote laboratory and a trained phlebotomist. Direct detection of SARS-CoV-2 antibodies from clinical saline gargle samples has been considered challenging due to the smaller number of antibodies in such specimens and the high limit of detection of currently available rapid tests. This work demonstrates simple and non-invasive methods for detecting SARS-CoV-2 salivary antibodies. Competitive particle immunoassays were developed on a paper microfluidic chip using the receptor-binding domain (RBD) antigens on spike proteins. Using a smartphone, they were monitored by counting the captured fluorescent particles or evaluating the capillary flow velocities. The limit of detection (LOD), cross-binding between alpha- and omicron-strains, and the effect of angiotensin-converting enzyme 2 (ACE2) presence were investigated. LODs were 1-5 ng/mL in both 10% and 1% saliva. Clinical saline gargle samples were assayed using both methods, showing a statistical difference between virus-negative and virus-positive samples, although the assays targeted antibodies. Only a small number of virus-positive samples were antibody-negative. The high assay sensitivity detected a small number of antibodies developed even during the early phase of infections. Overall, this work demonstrates the ability to detect SARS-CoV-2 salivary IgG antibodies on simple, cost-effective, portable platforms towards mitigating SARS-CoV-2 and potentially other respiratory viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, 85721, United States.
- Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States.
- Department of Ecology and Evolutionary Biology, The University of Arizona, Tucson, AZ, 85721, United States.
- Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, 85721, United States; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, United States. Electronic addres…
Förderung
- NIGMS NIH HHS
Zitieren
APA
Liang, Y., Buchanan, B. C., Khanthaphixay, B., Zhou, A., Quirk, G., Worobey, M., & Yoon, J. Y. (2023). Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms. Biosensors and Bioelectronics, 229, 115221. https://doi.org/10.1016/j.bios.2023.115221
Vancouver
Liang Y, Buchanan BC, Khanthaphixay B, Zhou A, Quirk G, Worobey M, et al. Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms. Biosensors and Bioelectronics. 2023;229:115221. doi:10.1016/j.bios.2023.115221
BibTeX
@article{Liang2023,
author = {Liang, Yan and Buchanan, Bailey C and Khanthaphixay, Bradley and Zhou, Avory and Quirk, Grace and Worobey, Michael and Yoon, Jeong-Yeol},
title = {Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {229},
pages = {115221},
doi = {10.1016/j.bios.2023.115221}
}
EUVIMED